Literature DB >> 8163165

Yeast TOR (DRR) proteins: amino-acid sequence alignment and identification of structural motifs.

R Cafferkey1, M M McLaughlin, P R Young, R K Johnson, G P Livi.   

Abstract

The yeast TOR1 (DRR1) and TOR2 (DRR2) proteins are putative targets of the immunosuppressive drug rapamycin (Rm), defined by dominant drug-resistance mutations. They share a large C-terminal domain that exhibits sequence similarity to the 110-kDa subunit of phosphatidylinositol (PI) 3-kinases. In this report, we present an amino acid (aa) sequence alignment of TOR1 (DRR1) and TOR2 (DRR2) and identify conserved and nonconserved motifs within the N-terminal domain that are indicative of possible nuclear localization. We also show that the mutations responsible for Rm resistance in four independent drr2dom alleles alter the identical aa (Ser1975-->Arg) previously identified in drr1dom mutants (Ser1972-->Arg or Asn). Models for TOR (DRR) protein function are discussed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8163165     DOI: 10.1016/0378-1119(94)90141-4

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  16 in total

1.  A defect in protein farnesylation suppresses a loss of Schizosaccharomyces pombe tsc2+, a homolog of the human gene predisposing to tuberous sclerosis complex.

Authors:  Yukiko Nakase; Keiko Fukuda; Yuji Chikashige; Chihiro Tsutsumi; Daisuke Morita; Shinpei Kawamoto; Mari Ohnuki; Yasushi Hiraoka; Tomohiro Matsumoto
Journal:  Genetics       Date:  2006-04-19       Impact factor: 4.562

2.  Convergence of TOR-nitrogen and Snf1-glucose signaling pathways onto Gln3.

Authors:  Paula G Bertram; Jae H Choi; John Carvalho; Ting-Fung Chan; Wandong Ai; X F Steven Zheng
Journal:  Mol Cell Biol       Date:  2002-02       Impact factor: 4.272

Review 3.  Yeast replicative aging: a paradigm for defining conserved longevity interventions.

Authors:  Brian M Wasko; Matt Kaeberlein
Journal:  FEMS Yeast Res       Date:  2013-10-30       Impact factor: 2.796

4.  Hypersensitivity to rapamycin of BJAB B lymphoblastoid cells.

Authors:  J E Kay; M C Smith; V Frost; G Y Morgan
Journal:  Immunology       Date:  1996-03       Impact factor: 7.397

5.  Cell wall integrity modulates RHO1 activity via the exchange factor ROM2.

Authors:  M Bickle; P A Delley; A Schmidt; M N Hall
Journal:  EMBO J       Date:  1998-04-15       Impact factor: 11.598

6.  A chemical genomics approach toward understanding the global functions of the target of rapamycin protein (TOR).

Authors:  T F Chan; J Carvalho; L Riles; X F Zheng
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-21       Impact factor: 11.205

Review 7.  Spatial regulation of the mTORC1 system in amino acids sensing pathway.

Authors:  Tsukasa Suzuki; Ken Inoki
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2011-07-23       Impact factor: 3.848

8.  The TOR nutrient signalling pathway phosphorylates NPR1 and inhibits turnover of the tryptophan permease.

Authors:  A Schmidt; T Beck; A Koller; J Kunz; M N Hall
Journal:  EMBO J       Date:  1998-12-01       Impact factor: 11.598

9.  TOR signaling is a determinant of cell survival in response to DNA damage.

Authors:  Changxian Shen; Cynthia S Lancaster; Bin Shi; Hong Guo; Padma Thimmaiah; Mary-Ann Bjornsti
Journal:  Mol Cell Biol       Date:  2007-08-13       Impact factor: 4.272

10.  Rapamycin Increases Mortality in db/db Mice, a Mouse Model of Type 2 Diabetes.

Authors:  Kavithalakshmi Sataranatarajan; Yuji Ikeno; Alex Bokov; Denis Feliers; Himabindu Yalamanchili; Hak Joo Lee; Meenalakshmi M Mariappan; Hooman Tabatabai-Mir; Vivian Diaz; Sanjay Prasad; Martin A Javors; Goutam Ghosh Choudhury; Gene B Hubbard; Jeffrey L Barnes; Arlan Richardson; Balakuntalam S Kasinath
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2015-10-05       Impact factor: 6.053

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.